Publication

Article

BioPharm International

BioPharm International-07-01-2002
Volume15
Issue 7

Guest Editorial: Supreme Court Rules on Festo

Author(s):

W. Murray Spruill, Ph.D., J.D.,Edward R. Ergenzinger, Jr.

Some good news, some bad news for biotechnology patent holders

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
Facilitating Client Audits: The Contract Laboratory Perspective
Facilitating Client Audits: The Contract Laboratory Perspective
Outsourcing Outlook: Optimizing Cross-Organizational Team Performance and Management
Analytical Advances: When an Industry Requires Multiterabyte Data Protection
Validation of Large-Scale Chromatographic Processes, Part 2: Results from the Case Study of Neuleze Capture on Macroprep High-S
Knowledge Management: The Four Pillars of Success
Inside Washington: One Hundred Years of Biotech Regulation

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey
How the 15% US-EU Tariff Cap Affects Bio/pharma
Related Content
Woman with pink ribbon on color background. Breast cancer awareness concept | Image Credit: © Pixel-Shot - stock.adobe.com
August 27th 2025

Daiichi Sankyo’s Breast Cancer Treatment, Enhertu, Approved in Japan

Patrick Lavery
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 27th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
small interfering RNA bound to a messenger RNA, cartoon model with semi-transparent surface. siRNAs are synthetic RNA interference tools used for inducing temporary reduction of mRNA expression. | Image Credit: © petarg - © petarg - stock.adobe.com
August 27th 2025

Hongene Expands exNA Technology Access for RNA Therapeutics Research with New Licensing Deal

Feliza Mirasol
Mastering Antibody-Drug Conjugates
August 27th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com
August 27th 2025

Novo Receives FDA 483 for Acquired Catalent Site

Christopher Cole
Human eye close-up in black and white. Extended pupil | Image Credit: © Annashou - stock.adobe.com
August 27th 2025

VeonGen’s Stargardt Disease Gene Therapy Gets FDA RMAT Status

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.